{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:32:37Z","timestamp":1782012757304,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Major international (regional) joint research project of National Science Foundation of China","award":["No. 81620108015"],"award-info":[{"award-number":["No. 81620108015"]}]},{"name":"Capital Characteristic and Clinical Application Research Fund from the Beijing Municipal Commission of Science and Technology","award":["No. Z161100000516110"],"award-info":[{"award-number":["No. Z161100000516110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10554-017-1263-3","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T02:04:52Z","timestamp":1508897092000},"page":"597-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase"],"prefix":"10.1007","volume":"34","author":[{"given":"Sainan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Hyeon","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"1263_CR1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65:1249\u20131254","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198903233201201","volume":"320","author":"P Spirito","year":"1989","unstructured":"Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C (1989) Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 320:749\u2013755","journal-title":"N Engl J Med"},{"key":"1263_CR3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1536\/ihj.25.805","volume":"25","author":"M Funakoshi","year":"1984","unstructured":"Funakoshi M, Imamura M, Sasaki J et al (1984) Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy. Jpn Heart J 25:805\u2013809","journal-title":"Jpn Heart J"},{"key":"1263_CR4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0735-1097(87)80301-7","volume":"9","author":"P Spirito","year":"1987","unstructured":"Spirito P, Maron BJ (1987) Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 9:1013\u20131017","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/clc.4960160507","volume":"16","author":"K Hina","year":"1993","unstructured":"Hina K, Kusachi S, Iwasaki K et al (1993) Progression of left ventricular enlargement in patients with hypertrophic cardiomyopathy: incidence and prognostic value. Clin Cardiol 16:403\u2013407","journal-title":"Clin Cardiol"},{"key":"1263_CR6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0002-9149(98)00164-7","volume":"81","author":"BJ Maron","year":"1998","unstructured":"Maron BJ, Spirito P (1998) Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 81:1339\u20131344","journal-title":"Am J Cardiol"},{"key":"1263_CR7","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/hrt.2003.031161","volume":"91","author":"R Thaman","year":"2005","unstructured":"Thaman R, Gimeno JR, Murphy RT et al (2005) Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy. Heart 91:920\u2013925","journal-title":"Heart"},{"key":"1263_CR8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","volume":"46","author":"E Biagini","year":"2005","unstructured":"Biagini E, Coccolo F, Ferlito M et al (2005) Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 46:1543\u20131550","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","volume":"114","author":"KM Harris","year":"2006","unstructured":"Harris KM, Spirito P, Maron MS et al (2006) Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114:216\u2013225","journal-title":"Circulation"},{"key":"1263_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cardfail.2011.01.015","volume":"17","author":"H Kawarai","year":"2011","unstructured":"Kawarai H, Kajimoto K, Minami Y, Hagiwara N, Kasanuki H (2011) Risk of sudden death in end-stage hypertrophic cardiomyopathy. J Card Fail 17:459\u2013464","journal-title":"J Card Fail"},{"key":"1263_CR11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4103\/0366-6999.157656","volume":"128","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Yang KQ, Yang YK et al (2015) Clinical characteristics and prognosis of end-stage hypertrophic cardiomyopathy. Chin Med J 128:1483\u20131489","journal-title":"Chin Med J"},{"key":"1263_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2016.04.053","volume":"216","author":"S Romano","year":"2016","unstructured":"Romano S, Jue J, White B, Farzaneh-Far A (2016) Evolution of hypertrophic cardiomyopathy assessed using serial cardiovascular magnetic resonance imaging. Int J Cardiol 216:156\u2013158","journal-title":"Int J Cardiol"},{"key":"1263_CR13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cardfail.2007.02.001","volume":"13","author":"F Matoh","year":"2007","unstructured":"Matoh F, Satoh H, Shiraki K et al (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 13:372\u2013379","journal-title":"J Card Fail"},{"key":"1263_CR14","doi-asserted-by":"crossref","first-page":"E24-28","DOI":"10.1002\/clc.20533","volume":"33","author":"T Hamada","year":"2010","unstructured":"Hamada T, Kubo T, Kitaoka H et al (2010) Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy. Clin Cardiol 33:E24-28","journal-title":"Clin Cardiol"},{"key":"1263_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jjcc.2012.08.010","volume":"61","author":"D Goto","year":"2013","unstructured":"Goto D, Kinugawa S, Hamaguchi S et al (2013) Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol 61:65\u201370","journal-title":"J Cardiol"},{"key":"1263_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mri.2013.10.011","volume":"32","author":"M Machii","year":"2014","unstructured":"Machii M, Satoh H, Shiraki K et al (2014) Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome. Magn Reson Imaging 32:118\u2013124","journal-title":"Magn Reson Imaging"},{"key":"1263_CR17","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","volume":"55","author":"American College of Cardiology Foundation Task Force on Expert Consensus Documents","year":"2010","unstructured":"American College of Cardiology Foundation Task Force on Expert Consensus Documents (2010) ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2614\u20132662","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867\u2013874","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","volume":"3","author":"R Rubinshtein","year":"2010","unstructured":"Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51\u201358","journal-title":"Circ Heart Fail"},{"key":"1263_CR20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","volume":"130","author":"RH Chan","year":"2014","unstructured":"Chan RH, Maron BJ, Olivotto I et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484\u2013495","journal-title":"Circulation"},{"key":"1263_CR21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","volume":"9","author":"Z Weng","year":"2016","unstructured":"Weng Z, Yao J, Chan RH et al (2016) Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging 9:1392\u20131402","journal-title":"JACC Cardiovasc Imaging"},{"key":"1263_CR22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jcmg.2016.01.032","volume":"9","author":"BJ Maron","year":"2016","unstructured":"Maron BJ, Maron MS (2016) LGE means better selection of HCM patients for primary prevention implantable defibrillators (editorial comment). JACC Cardiovasc Imaging 9:1403\u20131406","journal-title":"JACC Cardiovasc Imaging"},{"key":"1263_CR23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E et al (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"1263_CR24","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA et al (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35:2733\u20132779","journal-title":"Eur Heart J"},{"key":"1263_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12968-016-0236-3","volume":"18","author":"TT Le","year":"2016","unstructured":"Le TT, Tan RS, De Deyn M et al (2016) Cardiovascular magnetic resonance reference ranges for the heart and aorta in Chinese at 3T. J Cardiovasc Magn Reson 18:21","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"1263_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1532-429X-15-35","volume":"15","author":"J Schulz-Menger","year":"2013","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15(1):35","journal-title":"J Cardiovasc Magn Reson"},{"key":"1263_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","volume":"6","author":"G Moravsky","year":"2013","unstructured":"Moravsky G, Ofek E, Rakowski H et al (2013) Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging 6:587\u2013596","journal-title":"JACC Cardiovasc Imaging"},{"key":"1263_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539\u2013542","journal-title":"Circulation"},{"key":"1263_CR29","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","volume":"49","author":"T Kubo","year":"2007","unstructured":"Kubo T, Gimeno JR, Bahl A et al (2007) Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol 49:2419\u20132426","journal-title":"J Am Coll Cardiol"},{"key":"1263_CR30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.amjcard.2009.07.057","volume":"104","author":"E Biagini","year":"2009","unstructured":"Biagini E, Spirito P, Rocchi G et al (2009) Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy. Am J Cardiol 104:1727\u20131731","journal-title":"Am J Cardiol"},{"key":"1263_CR31","doi-asserted-by":"crossref","first-page":"e003090","DOI":"10.1161\/CIRCHEARTFAILURE.116.003090","volume":"9","author":"G Galati","year":"2016","unstructured":"Galati G, Leone O, Pasquale F et al (2016) Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy: a clinical-pathological study of 30 explanted hearts. Circ Heart Fail 9:e003090","journal-title":"Circ Heart Fail"},{"key":"1263_CR32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","volume":"349","author":"F Cecchi","year":"2003","unstructured":"Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG (2003) Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349:1027\u20131035","journal-title":"N Engl J Med"},{"key":"1263_CR33","first-page":"466","volume":"9","author":"B Pinamonti","year":"2008","unstructured":"Pinamonti B, Di Lenarda A, Nucifora G, Gregori D, Perkan A, Sinagra G (2008) Incremental prognostic value of restrictive filling pattern in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Eur J Echocardiogr 9:466\u2013471","journal-title":"Eur J Echocardiogr"},{"key":"1263_CR34","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517\u20132524","journal-title":"Circulation"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-017-1263-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-017-1263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-017-1263-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T02:27:48Z","timestamp":1521426468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-017-1263-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s10554-017-1263-3","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}